US 10758632
NIR-conjugated tumor-specific antibodies and uses thereof
granted A61KA61K2039/505A61K49/0002
Quick answer
US patent 10758632 (NIR-conjugated tumor-specific antibodies and uses thereof) held by The Regents of the University of California expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/505, A61K49/0002, A61K49/0032, A61K49/0058